Xencor Inc

NASDAQ:XNCR   3:59:57 PM EDT
37.26
-1.21 (-3.14%)
Products

Biocytogen Have Reached Agreement With Xencor, Inc., For Licensing Of Co's Fully Human Antibody Renmab/Renlite

Published: 12/07/2020 20:08 GMT
Xencor Inc (XNCR) - Biocytogen - Have Reached Agreement With Xencor, Inc., for Licensing of Co's Fully Human Antibody Renmab/renlite.